BioTechUSA Group Revenues Up, EBITDA Down in 2025

Despite the challenging economic environment, BioTechUSA Group, Hungarian-based retailer of nutritional supplements, managed to increase its revenue in 2025 after revenues rose to EUR 261.9 million, accompanied by an 11% increase in sales. However, the record turnover was accompanied by a slight decline in profitability. EBITDA fell from EUR 27 million to EUR 14.22 million due to persistently high raw material prices.

The comapny says in a statement that geopolitical conflicts, energy price volatility and difficulties in the supply of raw materials continued to strongly influence the dietary supplement and specialty food market in 2025. Nevertheless, the group maintained operational stability and market position in this environment. BioTechUSA Group is present in 104 countries, operate 51 webshops and have 332 physical stores across Europe. The company also works with over 4,800 B2B partners worldwide.

Growth in 2025 was primarily due to the expansion of the product range and distribution points, as well as a rethink of the pricing and promotional strategy. Combining B2B and B2C sales, BioTechUSA Group achieved net sales of EUR 261.9 million, while operating profit amounted to EUR 2.84 million and profit after tax to EUR 2.63 million. The company's equity increased to EUR 130.73 million, indicating a robust financial position and stable structure.

In 2025, the company continued to invest significant amounts in capital expenditure. Infrastructure developments worth EUR 23.5 million were completed, including automated logistics solutions, energy investments and a shaker logo plant. These developments will form the basis for increased efficiency in the coming period. The highlight of the investments was the handover of the new multilayer protein bar production line, which is currently in the testing phase. Once product development is complete later this year, BioTechUSA Group will begin production of the new type of protein bars.

The new production line has the capacity to manufacture 55 million products per year. Having tripled its capacity to 75 million slices per year, the production unit will play a key role in meeting demand for impulse and functional products. Another significant development in 2025 was the launch of a new range of organic vitamin products. Thanks to a multi-year partnership with FC Barcelona, BioTechUSA Group also introduced Iso Whey Zero protein powder in a Catalan cream flavor.

By 2025, BioTechUSA had further strengthened its presence in Europe and beyond. France, Germany, Slovakia and Spain remained the company's flagship markets, while the Czech Republic, Romania and the Balkan region also experienced significant growth. The mass retail channel, including hypermarkets, drugstores, and discount chains, closed the year with growth of over 20%. Additionally, pharmacies have become an increasingly important sales channel.